東京女子医科大学雑誌
Online ISSN : 2432-6178
Print ISSN : 0040-9022
ISSN-L : 0040-9022
総説 悪性腫瘍の最先端
(1)がんゲノム医療
山本 俊至
著者情報
ジャーナル フリー

2018 年 88 巻 1 号 p. 1-5

詳細
抄録

Precision cancer medicine is a medical practice that optimizes therapy, predicts prognosis, and prevents the onset of diseases through the use of genomic information from cancer tissues. Recent progress in comprehensive genetic analyses using next generation sequencing and various molecular targeted drugs for cancers with specific mutations have enabled us to use precision cancer medicine. When comprehensive genetic analyses are performed on cancer cells, many genetic mutations will be revealed. Among them, driver mutations in known therapeutic targets should be identified. For this purpose, the knowledge of bioinformatics is necessary. Furthermore, bioinformatics provides unintentional, secondary findings in about one in 10 people. Therefore, pre- and post-genetic counselling would be required. In conclusion, the use of precision cancer medicine should involve a team, so that it is implemented with correct understanding of the benefits obtained and the disadvantages that may occur due to comprehensive genome analyses.

著者関連情報
© 2018 東京女子医科大学学会
前の記事 次の記事
feedback
Top